Cargando…

The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022

The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. The main protease (M(pro)) of SARS-CoV-2 plays a central role in viral replication and transcription and represents an attractive drug target for fighting COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pang, Xiaojing, Xu, Wei, Liu, Yang, Li, Hua, Chen, Lixia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201905/ https://www.ncbi.nlm.nih.gov/pubmed/37244162 http://dx.doi.org/10.1016/j.ejmech.2023.115491

Ejemplares similares

Potential SARS-CoV-2 main protease inhibitors
por: Banerjee, Riddhidev, et al.
Publicado: (2021)

Developing inhibitors of the SARS-CoV-2 main protease
por: Seitz, Christian, et al.
Publicado: (2022)

Allosteric inhibitors of the main protease of SARS-CoV-2
por: Samrat, Subodh Kumar, et al.
Publicado: (2022)

Biochemical screening for SARS-CoV-2 main protease inhibitors
por: Coelho, Camila, et al.
Publicado: (2020)

Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors
por: Huff, Sarah, et al.
Publicado: (2021)

Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease
por: Katagishi, Daiki, et al.
Publicado: (2023)

Potent and biostable inhibitors of the main protease of SARS-CoV-2
por: Tsuji, Kohei, et al.
Publicado: (2022)

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
por: Mahdi, Mohamed, et al.
Publicado: (2020)

Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2
por: Abel, Renata, et al.
Publicado: (2020)

A cyclic peptide inhibitor of the SARS-CoV-2 main protease
por: Kreutzer, Adam G., et al.
Publicado: (2021)

Fragment-based inhibitor design for SARS-CoV2 main protease
por: Andola, Priyanka, et al.
Publicado: (2022)

Discovery of 3CLpro inhibitor of SARS-CoV-2 main protease
por: Kuang, Yi, et al.
Publicado: (2023)

Multicomponent Synthesis of the SARS-CoV-2 Main Protease Inhibitor Nirmatrelvir
por: Preschel, H. Daniel, et al.
Publicado: (2023)

Activation and maturation of SARS-CoV main protease
por: Xia, Bin, et al.
Publicado: (2011)

Non-conventional interactions of N3 inhibitor with the main protease of SARS-CoV and SARS-CoV-2
por: García-Gutiérrez, Ponciano, et al.
Publicado: (2021)

Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332
por: Zhao, Yao, et al.
Publicado: (2021)

Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease
por: Hemmati, Seyed Ali, et al.
Publicado: (2022)

Inhibitor binding influences the protonation states of histidines in SARS-CoV-2 main protease
por: Pavlova, Anna, et al.
Publicado: (2020)

Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2
por: Tripathi, Praveen Kumar, et al.
Publicado: (2020)

Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
por: Ghahremanpour, Mohammad M., et al.
Publicado: (2020)

Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
por: Mengist, Hylemariam Mihiretie, et al.
Publicado: (2021)

2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease
por: Forrestall, Katrina L., et al.
Publicado: (2021)

Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors
por: Shcherbakov, Dmitriy, et al.
Publicado: (2021)

Challenges of short substrate analogues as SARS-CoV-2 main protease inhibitors
por: Ullrich, Sven, et al.
Publicado: (2021)

A Genetic Trap in Yeast for Inhibitors of SARS-CoV-2 Main Protease
por: Alalam, Hanna, et al.
Publicado: (2021)

Hit Expansion of a Noncovalent SARS-CoV-2 Main Protease Inhibitor
por: Glaser, Jens, et al.
Publicado: (2022)

Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease
por: Somboon, Tuanjai, et al.
Publicado: (2021)

Action of Dipeptidyl Peptidase‐4 Inhibitors on SARS‐CoV‐2 Main Protease
por: Nar, Herbert, et al.
Publicado: (2021)

Discovery of 2-thiobenzimidazoles as noncovalent inhibitors of SARS-CoV-2 main protease
por: Deodato, Davide, et al.
Publicado: (2022)

Triterpenic Acid Amides as Potential Inhibitors of the SARS-CoV-2 Main Protease
por: Baev, Dmitry S., et al.
Publicado: (2022)

Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2
por: Zhang, Wenfa, et al.
Publicado: (2023)

Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors
por: Cardoso, Wesley B., et al.
Publicado: (2021)

The SARS-CoV-2 main protease as drug target
por: Ullrich, Sven, et al.
Publicado: (2020)

Topological analysis of SARS CoV-2 main protease
por: Estrada, Ernesto
Publicado: (2020)

Allosteric Hotspots in the Main Protease of SARS-CoV-2
por: Strömich, Léonie, et al.
Publicado: (2022)

Heparin interacts with the main protease of SARS-CoV-2 and inhibits its activity
por: Li, Jinwen, et al.
Publicado: (2022)

Computational identification of disulfiram and neratinib as putative SARS-CoV-2 main protease inhibitors
por: Stroylov, Victor S., et al.
Publicado: (2020)

Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors
por: Jiménez-Alberto, Alicia, et al.
Publicado: (2020)

2-Phenoxyacetamide derivatives as SARS-CoV-2 main protease inhibitor: In silico studies
por: Hariyono, Pandu, et al.
Publicado: (2022)

Apigenin analogues as SARS-CoV-2 main protease inhibitors: In-silico screening approach
por: Farhat, Ameny, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fdv43hrg4v0r38eap40clfj66u